Treatment gaps in epilepsy
- PMID: 38455298
- PMCID: PMC10910960
- DOI: 10.3389/fepid.2022.976039
Treatment gaps in epilepsy
Abstract
Over 50 million people around the world have epilepsy, and yet, epilepsy recognition and access to care are ongoing issues. Nearly 80% of people with epilepsy live in low-and middle-income countries and face the greatest barriers to quality care. However, there are substantial disparities in care within different communities in high-income countries as well. Across the world, under-recognition of seizures continues to be an issue, leading to diagnostic and treatment delays. This stems from issues surrounding stigma, public education, basic access to care, as well as healthcare worker education. In different regions, people may face language barriers, economic barriers, and technological barriers to timely diagnosis and treatment. Even once diagnosed, people with epilepsy often face gaps in optimal seizure control with the use of antiseizure medications. Additionally, nearly one-third of people with epilepsy may be candidates for epilepsy surgery, and many either do not have access to surgical centers or are not referred for surgical evaluation. Even those who do often experience delays in care. The purpose of this review is to highlight barriers to care for people with epilepsy, including issues surrounding seizure recognition, diagnosis of epilepsy, and the initiation and optimization of treatment.
Keywords: accessibility; barriers; diagnoisis; disparities; healthcare delivery; neurology; underutilization.
Copyright © 2022 Pellinen.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment.Epilepsia. 2022 Feb;63(2):335-351. doi: 10.1111/epi.17155. Epub 2022 Jan 3. Epilepsia. 2022. PMID: 34981508
-
E = mc2 : Education (E), medication (m), and conditional cash (c2 ) to improve uptake of antiseizure medications in a low-resource population: Protocol for randomized trial.Epilepsia Open. 2024 Feb;9(1):445-454. doi: 10.1002/epi4.12889. Epub 2024 Jan 4. Epilepsia Open. 2024. PMID: 38131270 Free PMC article.
-
Barriers to and Disparities in Access to Health Care Among Adults Aged ≥18 Years with Epilepsy - United States, 2015 and 2017.MMWR Morb Mortal Wkly Rep. 2022 May 27;71(21):697-702. doi: 10.15585/mmwr.mm7121a1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35617131 Free PMC article.
-
Underutilization of epilepsy surgery: Part I: A scoping review of barriers.Epilepsy Behav. 2021 Apr;117:107837. doi: 10.1016/j.yebeh.2021.107837. Epub 2021 Feb 18. Epilepsy Behav. 2021. PMID: 33610461 Free PMC article.
-
Epilepsy in Asia: Disease burden, management barriers, and challenges.Epilepsia. 2019 Mar;60 Suppl 1:7-21. doi: 10.1111/epi.14458. Epub 2018 Jun 28. Epilepsia. 2019. PMID: 29953579 Review.
Cited by
-
Knowledge, attitudes, and practices of caregivers with children diagnosed with epilepsy attending a pediatric outpatient clinic: a descriptive, cross-sectional, questionnaire-based study in Addis Ababa, Ethiopia.BMC Neurol. 2024 Jul 22;24(1):252. doi: 10.1186/s12883-024-03766-1. BMC Neurol. 2024. PMID: 39039504 Free PMC article.
-
Using electronic medical records to analyze outpatient visits of persons with epilepsy during the pandemic-experience from a low middle income country.Acta Epileptol. 2025 Jan 15;7(1):6. doi: 10.1186/s42494-024-00192-1. Acta Epileptol. 2025. PMID: 40217558 Free PMC article.
-
Caregivers' experiences and challenges of the diagnostic odyssey in Dravet syndrome.Orphanet J Rare Dis. 2025 May 16;20(1):234. doi: 10.1186/s13023-025-03772-7. Orphanet J Rare Dis. 2025. PMID: 40380275 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources